Detalhe da pesquisa
1.
The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria.
Hum Mol Genet
; 33(10): 919-929, 2024 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339995
2.
Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria.
Hemoglobin
; 43(3): 188-192, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31462098
3.
Genetic Polymorphisms of Glucose-6-Phosphate Dehydrogenase in Lagos, Nigeria.
Hemoglobin
; 42(1): 47-50, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493303
4.
Health related quality of life and perception of stigmatisation in adolescents living with sickle cell disease in Nigeria: A cross sectional study.
Pediatr Blood Cancer
; 62(7): 1245-51, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810358
5.
Fetal-haemoglobin enhancing genotype at BCL11A reduces HbA2 levels in patients with sickle cell anaemia.
EJHaem
; 2(3): 459-461, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844678
6.
Current perspectives of sickle cell disease in Nigeria: changing the narratives.
Expert Rev Hematol
; 12(8): 609-620, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31195888
7.
Impact of training of mothers, drug shop attendants and voluntary health workers on effective diagnosis and treatment of malaria in Lagos, Nigeria.
Trop Parasitol
; 9(1): 36-44, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31161091
8.
A survey of genetic fetal-haemoglobin modifiers in Nigerian patients with sickle cell anaemia.
PLoS One
; 13(6): e0197927, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879141